Evan A. Mulligan

19 papers and 902 indexed citations i.

Evan A. Mulligan has authored 19 papers that have received a total of 902 indexed citations. This includes 12 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Genetics. The topics of these papers are PARP inhibition in cancer therapy (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Genetically Modified Organisms Research (5 papers). Evan A. Mulligan is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Genetically Modified Organisms Research (5 papers) and collaborates with scholars based in United Kingdom, United States and France. Evan A. Mulligan's co-authors include Nicola J. Curtin, Angharad M. R. Gatehouse, N. Ferry, Huw D. Thomas and Zdeněk Hostomský and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer Research.